Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Annovis Bio Inc (NY: ANVS )

34.43 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,248
Open 34.43
Bid (Size) 36.50 (2)
Ask (Size) 37.58 (1)
Prev. Close 34.43
Today's Range 34.43 - 34.43
52wk Range 4.140 - 132.00
Shares Outstanding 8,100,570
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
(ANVS) Alert: Johnson Fistel Investigates Annovis Bio, Inc. Following FDA Notification. Did You Lose Money on Your Investment?
From GlobeNewswire News Releases
Investigation Alert: Bernstein Litowitz Berger & Grossmann LLP Announces Investigation of Annovis Bio, Inc. and Encourages Investors to Contact the Firm
Prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") is investigating potential violations of the federal securities laws by Annovis Bio, Inc. ("Annovis" or the... 
From PR Newswire

Performance

YTD
+322.45%
+322.45%
1 Month
-64.51%
-64.51%
3 Month
+59.03%
+59.03%
6 Month
+235.90%
+235.90%
1 Year
+499.83%
+499.83%

More News

Read More
ANVS Stock: The Alzheimer’s Drug News That Has Annovis Bio Plunging Today
Tags Today's Market ANVS NYSEAMERICAN:ANVS
From InvestorPlace
Annovis Bio Shares Cut In Half Following Alzheimer's Data Presentation
Tags BIIB Small Cap Biotech
From Benzinga
Mid-Day Market Update: LendingClub Surges Following Strong Q2 Results; Atreca Shares Plummet
Tags Mid/Day Market Update Information Technology News
From Benzinga
Mid-Morning Market Update: Markets Open Higher; Mastercard Profit Beats Estimates
Tags Earnings Benzinga Markets
From Benzinga
Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday
Tags ANVS Market News SAVA
From Motley Fool
Annovis Bio Stock Crashes After Much-Hyped Alzheimer's Drug Flops In Midstage Test
From Investor's Business Daily
Thinking about trading options or stock in MicroStrategy, Coinbase Global, Annovis Bio, Hasbro, or Overstock.com?
From PR Newswire
Annovis Bio's Alzheimer's Candidate To Proceed Into Final Cohort Of Mid-Stage Study, Data Expected In 2022
Tags Market News Health Care Benzinga
From Benzinga
Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.